Hepatitis B DNA vaccine - GENimmune
Alternative Names: EP 2210; EP-HBS; GCR 3697; GNI-102; HBV DNA vaccine - Pharmexa-Epimmune/Innogenetics; HBV polyepitope vaccine - GENimmune; Hepatitis B Virus polyepitope vaccine candidate - GENimmune; INNO 102; INX-102-3697Latest Information Update: 14 Oct 2008
At a glance
- Originator Genencor International; Pharmexa-Epimmune
- Developer GENimmune
- Class DNA vaccines; Hepatitis B vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hepatitis B
Most Recent Events
- 12 Feb 2008 Discontinued - Phase-I for Hepatitis B in USA (IM)
- 12 Feb 2008 GNI 102 is available for licensing (http://www.genimmune-nv.com)
- 27 Nov 2007 This vaccine is still in active development